ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 23,496 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 23,496 | -0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 23,497 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 23,497 | -97.7% | 0.00% | – |
| Q4 2019 | $21,000 | -22.2% | 1,000,000 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | – | 1,000,000 | -90.0% | 0.00% | – |
| Q2 2019 | $0 | – | 10,000,000 | +3497.1% | 0.00% | – |
| Q1 2019 | $0 | – | 278,000 | -93.1% | 0.00% | – |
| Q4 2018 | $0 | – | 4,028,000 | +64.6% | 0.00% | – |
| Q3 2018 | $0 | – | 2,447,000 | +333.9% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 564,000 | -9.8% | 0.00% | -100.0% |
| Q2 2017 | $536,000 | -29.5% | 625,000 | -37.5% | 0.00% | -50.0% |
| Q4 2016 | $760,000 | +223.4% | 1,000,000 | +277.4% | 0.00% | +100.0% |
| Q1 2016 | $235,000 | -23.0% | 265,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $305,000 | -81.7% | 265,000 | -83.5% | 0.00% | -80.0% |
| Q3 2014 | $1,663,000 | – | 1,603,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |